Application of XOLAIR® (Omalizumab) in adolescent refractory chest tightness variant asthma.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202208_29522
Abstract: BACKGROUND Asthma can manifest in a variety of clinical phenotypes like cough variant asthma, chest tightness variant asthma (CTVA), and masked asthma. Patients with CTVA usually have a singular or primary complaint of chest tightness,… read more here.
Keywords: application xolair; tightness; variant asthma; tightness variant ... See more keywords